As of June 2025, according to Cintas's current financial statements, the company's 12-month EPS is $4.39. For the year 2024, the company recorded an earnings per share (EPS) of $3.85, which marks an increase compared to its EPS of $3.3 in 2023. Cintas's earnings per share for the quarterly report ending on Feb 28, 2025 reached $1.14.
The annual EPS for the year 2024 was $3.85, an increase of 16.7% from $3.3 in 2023. For the fiscal quarter that ended on Feb 28, 2025, the per-share earnings was $1.14, showing a 16.3% increase from the same quarter last year. For the twelve months ending February 2025, the EPS is $4.39. For the year 2023, the yearly earnings per share was $3.3, marking an increase of 10.7% from 2022.
During the last 12 months, Cintas has seen an EPS growth of 16.3% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 13.5% per year. During the last 5 years, the company had an average EPS growth rate of 13.3%. When measured over a ten-year period, CTAS's average EPS growth rate was 17.5%.
Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
---|---|---|---|---|
GNTX Gentex Corp | 12.47 | -3.8% | 5.4% | 1.2% |
UNF Unifirst Corp | 22.06 | 40.6% | -0.8% | -3.7% |
HCSG Healthcare Services Group Inc | 25.44 | 3.8% | -6% | -9.1% |
ARMK Aramark | 29.88 | -61.4% | N/A | -11.3% |
ABM Abm Industries Inc | 35.35 | -66.1% | -11.6% | -7.5% |
CTAS Cintas Corp | 50.41 | 16.7% | 13.5% | 13.3% |
All data is based on quarterly TTM periods, unless otherwise specified.